Over 20 years, 8.4% of patients with lupus developed end-stage kidney disease, a study found. Investigators have identified risk factors for development of end-stage kidney disease (ESKD) after a ...

Certain autoantibodies were significantly associated with neuropsychiatric manifestations of systemic lupus erythematosus, emphasizing their utility for accurately diagnosing and managing this complex ...

New research identifies age, anti-β2GP1 antibodies, and low complement C3 as key risk factors for cerebral small vessel ...

Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...

Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...